Depressive disorder
Therapeutic area
Psychiatry
Rare disease
No
- Definition
- A melancholy feeling of sadness and despair.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Depressive disorder
- Therapeutic area
- Psychiatry
- depressive disorder
- depression
- melancholia
- melancholias
- syndrome, depressive
- syndromes, depressive
- Severity
- Mild
- Neurology
- Psychiatry
- MONDO ID
- MONDO:0002050
- Parent condition
- MONDO:0005371
Related records
Broader conditions (10)
- Brain disorder
- Central nervous system disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Mental disorder
- Mood disorder
- Nervous system disorder
- Psychiatric disorder
Narrower conditions (8)
- Bipolar depression
- Endogenous depression
- Major depressive disorder
- Melancholia
- Mixed anxiety and depressive disorder
- Neurotic depression
- Postpartum depression
- Seasonal affective disorder
Trials (8,861)
- 'Nurture and Play' - a Pilot Study
- "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
- "Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"
- "Becoming Parents": A Hospital-community Partnership
- "Consultation Liaison and Integrated Care for COPD Patients With Psychiatric Co-Morbidity"
- "Culturally Adapted CBT for Depression in Arab and Asian Adolescents in the UAE (CA-CBT)"
- "Erectile Function After PCI in MI and Non-MI Patients"
- "Machine Learning Analysis of Lingual Colorimetry and MADRS Anxiety-Depression Score in Acupuncture Patients"
- "Mindfulness vs Psychoeducation in Bipolar Disorder"
- "VRTierOne" as a Method Supporting the Post-stroke Rehabilitation
- "Youth Aware of Mental Health" in Galicia
- (Cost-)Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Cancer Patients
- (GluEsk) Glutamate and Esketamine
- [11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine
- [18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
- #Stayhealthy - Monitoring and Maintenance of Mental Health Under Conditions of Social Isolation During the Corona Crisis
- 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
- 10-year Follow-up After Aortic Valve Replacement Surgery
- 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
- 2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation
Approved drugs (37)
- Agomelatine
- Amitriptyline
- Aripiprazole
- Brexanolone
- Bupropion
- Bupropion hydrochloride
- Buspirone hydrochloride
- Citalopram
- Clomipramine
- Desipramine
- Desvenlafaxine
- Doxepin
- Escitalopram
- Esketamine
- Esketamine hydrochloride
- Fluvoxamine
- Folic acid
- Imipramine
- Lamotrigine
- Lithium carbonate
Drugs in development (244)
- (D)-serine Phase 1
- Acamprosate Phase 3
- Acetylcysteine Early phase 1
- Ademetionine Phase 2
- Adenosine triphosphate Phase 2
- Alprazolam Phase 3
- Amibegron Phase 3
- Amisulpride Phase 3
- Amlodipine Phase 3
- Armodafinil Phase 3
- Ascorbic acid Phase 2
- Aspirin Phase 2
- Atorvastatin Phase 2
- AV-101 Phase 2
- Azetukalner Phase 1
- Basimglurant Phase 2
- Beloxepin Phase 1
- Benperidol Phase 3
- Bifeprunox Phase 3
- Biperiden Phase 3
Other linked drugs (21)
- Aprepitant
- Benactyzine
- Carbidopa
- Gepirone
- Glaziovine
- Imipramine pamoate
- Isocarboxazid
- Levodopa
- Minaprine
- Nefazodone
- Omeprazole
- Osanetant
- Phenelzine
- Pizotyline
- Progabide
- Protriptyline
- Testosterone
- Tryptophan
- Uridine
- Vortioxetine hydrobromide